ClinicalTrials.gov
ClinicalTrials.gov Menu

Age-adjusted D-dimer Cut-off to Rule Out Pulmonary Embolism in the Emergency Department : A Real Life Impact Study (RELAX-PE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02601846
Recruitment Status : Recruiting
First Posted : November 10, 2015
Last Update Posted : October 26, 2016
Sponsor:
Collaborators:
University Hospital, Brest
The Ottawa Hospital
European Georges Pompidou Hospital
University Hospital St Luc, Brussels
Centre Hospitalier Universitaire Vaudois
University Hospital, Angers
Information provided by (Responsible Party):
Helia Robert-Ebadi, University Hospital, Geneva

Brief Summary:

A multicentre multinational prospective management outcome study has recently proven the safety of a diagnostic strategy combining clinical probability assessment with an age-adjusted D-dimer cut-off, defined as a value of (age x 10) in patients > 50 years, for ruling out PE in outpatients, with a very low likelihood of subsequent symptomatic VTE. Moreover, this study showed that such a strategy increased the diagnostic yield of D-dimers, as it allowed ruling out PE without further investigation in a significantly higher proportion of patients than when using standard cut-off, particularly so in patients 75 years or older.

The objective of the present study is to confirm in a prospective cohort of "real life" patients the usefulness of the age-adjusted D-dimer cut-off to rule out PE in patients presenting to the emergency department with suspected PE.


Condition or disease Intervention/treatment
Pulmonary Embolism Other: No intervention

  Show Detailed Description

Study Type : Observational
Estimated Enrollment : 1100 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Age-adjusted D-dimer Cut-off to Rule Out Pulmonary Embolism in the Emergency Department : A Real Life Impact Study
Study Start Date : November 2015
Estimated Primary Completion Date : December 2018
Estimated Study Completion Date : March 2019

Resource links provided by the National Library of Medicine



Intervention Details:
  • Other: No intervention
    This is an observational study, without any specific intervention.


Primary Outcome Measures :
  1. The incidence of symptomatic thromboembolic events (objectively confirmed pulmonary embolism and/or deep vein thrombosis) during follow-up in patients with D-dimer levels below age-adjusted cutoff [ Time Frame: Three months ]

Secondary Outcome Measures :
  1. Proportion of patients with a non-high clinical probability and a D-dimer result between 500µg/L and their age-adjusted cut-off value [ Time Frame: Three months ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
All consecutive patients admitted to the emergency department with suspected PE defined as acute onset of new or worsening shortness of breath or chest pain without any other obvious etiology in whom PE has been considered ruled out by negative D-dimers using an age-adjusted cut-off will be screened for inclusion. Those with non-high probability and negative D-dimers (PE excluded by the non-invasive strategy using "new" D-dimer cut-offs) will be included and followed-up for 3 months. The aim of including both patients above and under 50 years of age is to be able to compare the difference in thromboembolic event rates between patients with a D-dimer level between 500 µg/L and their age-ajusted cut-off and those with a D-dimer < 500 µg/L.
Criteria

Inclusion Criteria:

  • Consecutive out patients with suspected PE in whom PE has been considered ruled out by negative D-dimers using an age-adjusted cut-off.

Exclusion Criteria:

  • Life expectancy less than 3 months.
  • Geographic inaccessibility for follow-up.
  • Therapeutic anticoagulation for any indication.
  • Pregnancy.
  • Age less than 18.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02601846


Contacts
Contact: Helia Robert-Ebadi, MD helia.robert-ebadi@hcuge.ch
Contact: Marc Righini, MD marc.righini@hcuge.ch

Locations
Belgium
Cliniques Universitaires Saint-Luc Recruiting
Brussels, Belgium
Contact: Franck Verschuren, MD       franck.verschuren@uclouvain.be   
Principal Investigator: Franck Verschuren, MD         
CHU de Liège Recruiting
Liege, Belgium
Contact: Alexandre Ghuysen, MD       a.ghuysen@chu.ulg.ac.be   
Principal Investigator: Alexandre Ghuysen, MD         
Switzerland
Hôpital Fribourgeois HFR Not yet recruiting
Fribourg, Switzerland
Contact: Daniel Hayoz, MD       Daniel.Hayoz@h-fr.ch   
Principal Investigator: Daniel Hayoz, MD         
Geneva University Hospitals Recruiting
Geneva, Switzerland
Contact: Helia Robert-Ebadi, MD       helia.robert-ebadi@hcuge.ch   
Principal Investigator: Helia Robert-Ebadi, MD         
Principal Investigator: Marc Righini, MD         
Centre Hospitalier Universitaire Vaudois Recruiting
Lausanne, Switzerland
Contact: Olivier Hügli, MD       Olivier.Hugli@chuv.ch   
Groupement Hospitalier de l'Ouest Lémanique Recruiting
Nyon, Switzerland
Contact: Thierry Fumeaux, MD       thierry.fumeaux@ghol.ch   
Principal Investigator: Thierry Fumeaux, MD         
Sponsors and Collaborators
University Hospital, Geneva
University Hospital, Brest
The Ottawa Hospital
European Georges Pompidou Hospital
University Hospital St Luc, Brussels
Centre Hospitalier Universitaire Vaudois
University Hospital, Angers
Investigators
Principal Investigator: Helia Robert-Ebadi, MD Geneva University Hospitals and Faculty of Medicine

Publications:
Responsible Party: Helia Robert-Ebadi, Principal Investigator, University Hospital, Geneva
ClinicalTrials.gov Identifier: NCT02601846     History of Changes
Other Study ID Numbers: Geneva 15-010
First Posted: November 10, 2015    Key Record Dates
Last Update Posted: October 26, 2016
Last Verified: October 2016

Additional relevant MeSH terms:
Emergencies
Embolism
Pulmonary Embolism
Disease Attributes
Pathologic Processes
Embolism and Thrombosis
Vascular Diseases
Cardiovascular Diseases
Lung Diseases
Respiratory Tract Diseases
Fibrin fragment D
Antifibrinolytic Agents
Fibrin Modulating Agents
Molecular Mechanisms of Pharmacological Action
Hemostatics
Coagulants